ASMB
Price:
$16.99
Market Cap:
$107.81M
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutus Biopharma Corporation; and Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection...[Read more]
Industry
Biotechnology
IPO Date
2010-12-17
Stock Exchange
NASDAQ
Ticker
ASMB
According to Assembly Biosciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.96. This represents a change of 38.41% compared to the average of -1.42 of the last 4 quarters.
The mean historical PE Ratio of Assembly Biosciences, Inc. over the last ten years is -43.89. The current -1.96 PE Ratio has changed 346.59% with respect to the historical average. Over the past ten years (40 quarters), ASMB's PE Ratio was at its highest in in the June 2020 quarter at 339.77. The PE Ratio was at its lowest in in the December 2017 quarter at -913.34.
Average
-43.89
Median
-16.63
Minimum
-225.15
Maximum
-0.68
Discovering the peaks and valleys of Assembly Biosciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 296.79%
Maximum Annual PE Ratio = -0.68
Minimum Annual Increase = -91.93%
Minimum Annual PE Ratio = -225.15
Year | PE Ratio | Change |
---|---|---|
2023 | -0.74 | 7.62% |
2022 | -0.68 | -11.98% |
2021 | -0.78 | -78.43% |
2020 | -3.60 | -34.57% |
2019 | -5.50 | -91.93% |
2018 | -68.20 | -69.71% |
2017 | -225.15 | 296.79% |
2016 | -56.74 | 14.10% |
2015 | -49.73 | 79.22% |
2014 | -27.75 | -39.43% |
The current PE Ratio of Assembly Biosciences, Inc. (ASMB) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.73
5-year avg
-2.26
10-year avg
-43.89
Assembly Biosciences, Inc.’s PE Ratio is less than Spero Therapeutics, Inc. (4.06), less than Achilles Therapeutics plc (-0.45), less than Instil Bio, Inc. (-0.78), less than Neoleukin Therapeutics, Inc. (-0.98), less than CytomX Therapeutics, Inc. (9.19), less than Nuvation Bio Inc. (-1.34), less than NextCure, Inc. (-0.65),
Company | PE Ratio | Market cap |
---|---|---|
4.06 | $71.07M | |
-0.45 | $29.58M | |
-0.78 | $92.68M | |
-0.98 | $8.20M | |
9.19 | $93.74M | |
-1.34 | $692.60M | |
-0.65 | $39.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assembly Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Assembly Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Assembly Biosciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Assembly Biosciences, Inc. (ASMB)?
What is the highest PE Ratio for Assembly Biosciences, Inc. (ASMB)?
What is the 3-year average PE Ratio for Assembly Biosciences, Inc. (ASMB)?
What is the 5-year average PE Ratio for Assembly Biosciences, Inc. (ASMB)?
How does the current PE Ratio for Assembly Biosciences, Inc. (ASMB) compare to its historical average?